Framycetin(CAS: 119-04-0)

Framycetin (CAS: 119-04-0) is regulated under the GHS (Global Harmonized System of Classification and Labeling of Chemicals) for hazardous communication. It falls under REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the European Union, requiring manufacturers and importers to register substances if they are manufactured or imported in quantities greater than 1 tonne annually. In the United States, FDA and EPA have specific labeling and handling requirements due to its potential toxicity.

Framycetin (CAS: 119-04-0) is an antibiotic, and alternatives include other antibiotics such as polymyxin B, colistin, and tigecycline. Isomers and analogs like framycetin sulfate can also be considered. Common alternative reagents in its synthesis include amino acids, sugars, and other organic compounds depending on the specific synthesis route.

The market for Framycetin (CAS: 119-04-0) has shown stability, but research trends are shifting towards understanding its mechanisms of action and exploring its potential in combination therapies. Recent studies focus on its effectiveness against multidrug-resistant pathogens. Market trends indicate growing interest in antimicrobial research, driven by the increasing prevalence of drug-resistant infections.

Waste containing Framycetin (CAS: 119-04-0) should be collected in appropriate containers and labeled as hazardous. Incineration is a common method for waste disposal, but professional waste disposal services should be used. Environmental protection measures should include proper storage and handling to prevent leaks, with precautionary measures to avoid exposure to the environment. Compliance with local, national, and international regulations is essential.